Lead Digital Marketing
Harrow
Lead Digital Marketing
Harrow
Compounds ophthalmic formulations; markets branded drugs
Before reading the job post, we encourage you to watch this video about our company. It gives you an inside look at how we started, the team and culture that made us successful, and where we're going. It's easy to read a job post and apply, but people often wonder about the culture and whether they would fit in. If you want to call Harrow your home and genuinely want to be part of a family and something big, then we encourage you to click this link and get to know us.
Who is Harrow?
Harrow (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America. Harrow is an incredible entrepreneurial company – where we celebrate the ability of every member of the Harrow Family to be the CEO of their job. Harrow’s values have driven interest over the past decade in attracting high-performing professionals in a variety of disciplines. Members of our Harrow Family often express their pride in being a part of our commitment to (1) innovation, (2) patient access to affordable medicines, and (3) our track record of having never turned down an ophthalmologist doing mission work around the world – providing free medicines in support of mission work aimed at giving or maintaining the gift of sight to those most in need. We encourage you to learn more about Harrow and its unique culture to see if you’re the right person to help contribute as we build a truly exceptional company, one we are all so proud of!
Harrow’s ophthalmic pharmaceutical portfolio is one of the most comprehensive in the industry, including:
Lead, Digital Marketing
Harrow | Reports to: Head, Marketing
Owns Harrow’s enterprise digital marketing platform across all three franchises: social media, omnichannel campaigns, paid media, website and SEO, and digital measurement. Runs one shared intake queue so every brand gets digital capability without duplicating headcount.
Comp: $230,000 Plus Bonus
Harrow is a publicly traded ophthalmic pharmaceutical company that combines a compounding business (ImprimisRx) with a growing portfolio of FDA-approved branded drugs and biotech ventures. It delivers customized compounded sterile and topical eye medications directly to physicians and patients, and also markets branded drugs and biosimilars like ILEVRO, MAXITROL, and VEVYE, plus retinal-disease biosimilars. It differentiates itself by owning production and distribution facilities, being licensed in all 50 states, and growing through acquisitions to broaden its portfolio, along with investments in Melt Pharmaceuticals and Surface Ophthalmics. Its goal is to provide accessible, high-quality eye medications and to build a broad, vertically integrated ophthalmology platform serving surgeons, hospitals, and patients nationwide.
Explore more opportunities at Harrow